Quart Barry D

Director at KNSA; Chief Executive Officer at HRTX; Director at TRIMERIS INC, and 1 more

Sold, on record
$15.8M
Dollars the filings state
Form 4 sales
23
Latest Apr 28, 2026
Form 144 notices
0
Proposed sales
Companies
4
Filed as an executive or holder

Companies

Sales by reason

5
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale HRTXUnusual
    Jun 21 2018

    Sold 50,000 shares at $39.05 ($2M)

    Quart Barry D, Chief Executive Officer

    Sold 41.8% of holdings ($4.7M position)69,600 shares leftFiling

  2. 2 Form 4 sale KNSAUnusual
    Nov 29 +1622 days

    Sold 21,959 shares at $16.15 ($355k)

    Quart Barry D, Director

    Sold 100% of holdings ($355k position)0 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale KNSAUnusual
    Jun 11 +925 days

    Sold 27,448 shares at $30.35 ($833k)

    Quart Barry D, Director

    No 10b5-1 planSold 68.6% of holdings ($1.2M position)12,546 shares leftFirst sale on recordFiling

  4. 4 Form 4 sale KNSARoutine
    Dec 15 +187 days

    Sold 20,129 shares at $41.51 ($836k)

    Quart Barry D, Director

    10b5-1 planSold 61.6% of holdings ($1.4M position)12,546 shares leftFiling

  5. 5 Form 4 sale KNSARoutine
    Feb 4 +51 days

    Sold 15,960 shares at $45.22 ($722k)

    Quart Barry D, Director

    10b5-1 planSold 56% of holdings ($1.3M position)12,546 shares leftFiling

  6. 6 Form 4 sale KNSARoutine
    Feb 12 +8 days

    Sold 2,800 shares at $45.00 ($126k)

    Quart Barry D, Director

    10b5-1 planSold 18.2% of holdings ($691k position)12,546 shares left0.1x usual sizeFiling

  7. 7 Form 4 sale KNSARoutine
    Apr 6 +53 days

    Sold 6,901 shares at $50.00 ($345k)

    Quart Barry D, Director

    10b5-1 planSold 35.5% of holdings ($972k position)12,546 shares left0.4x usual sizeFiling

  8. 8 Form 4 sale KNSARoutine
    Apr 28 +22 days

    Sold 13,099 shares at $50.10 ($656k)

    Quart Barry D, Director

    10b5-1 planSold 51.1% of holdings ($1.3M position)12,546 shares left0.8x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (23)

Form 144 notices and Form 4 sales by Quart Barry D
Source
Apr 28, 2026KNSADirectorForm 4 sale13,099$656k51.1%RoutineSEC
Apr 6, 2026KNSADirectorForm 4 sale6,901$345k35.5%RoutineSEC
Feb 12, 2026KNSADirectorForm 4 sale2,800$126k18.2%RoutineSEC
Feb 4, 2026KNSADirectorForm 4 sale15,960$722k56.0%RoutineSEC
Dec 15, 2025KNSADirectorForm 4 sale20,129$836k61.6%RoutineSEC
Jun 11, 2025KNSADirectorForm 4 sale27,448$833k68.6%UnusualSEC
Nov 29, 2022KNSADirectorForm 4 sale21,959$355k100.0%UnusualSEC
Jun 21, 2018HRTXChief Executive OfficerForm 4 sale50,000$2M41.8%UnusualSEC
Mar 19, 2018HRTXChief Executive OfficerForm 4 sale100,000$3M59.5%UnusualSEC
Mar 14, 2018HRTXChief Executive OfficerForm 4 sale100,000$2.5M59.5%UnusualSEC
Mar 2, 2015HRTXChief Executive OfficerForm 4 sale10,000$131k18.9%Plan not statedSEC
Jun 20, 2014TRIMERIS INCDirectorForm 4 sale1,375$138k100.0%UnusualSEC
Jun 17, 2014TRIMERIS INCDirectorForm 4 sale1,000$90k100.0%UnusualSEC
Jun 12, 2014TRIMERIS INCDirectorForm 4 sale1,000$83k100.0%UnusualSEC
May 9, 2011INTRABIOTICS PHARMACEUTICALS INC /DEPresident and CEOForm 4 sale20,000$544k24.3%Plan not statedSEC
Feb 7, 2011INTRABIOTICS PHARMACEUTICALS INC /DEPresident and CEOForm 4 sale20,000$535k29.8%UnusualSEC
Dec 8, 2010INTRABIOTICS PHARMACEUTICALS INC /DEPresident and CEOForm 4 sale20,000$438k35.0%UnusualSEC
Aug 9, 2010INTRABIOTICS PHARMACEUTICALS INC /DEPresident and CEOForm 4 sale20,000$404k32.3%UnusualSEC
May 7, 2010INTRABIOTICS PHARMACEUTICALS INC /DEPresident and CEOForm 4 sale25,000$530k37.6%UnusualSEC
Feb 8, 2010INTRABIOTICS PHARMACEUTICALS INC /DEPresident and CEOForm 4 sale25,000$364k53.7%UnusualSEC
Dec 9, 2009INTRABIOTICS PHARMACEUTICALS INC /DEPresident and CEOForm 4 sale25,000$362k40.3%UnusualSEC
Aug 11, 2009INTRABIOTICS PHARMACEUTICALS INC /DEPresident and CEOForm 4 sale25,000$483k60.2%UnusualSEC
May 19, 2009INTRABIOTICS PHARMACEUTICALS INC /DEPresident and CEOForm 4 sale25,000$385k48.5%UnusualSEC